Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-16 of 16
Keywords: neuroblastoma
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Ewa Rejnowicz, Matthew Batchelor, Eoin Leen, Mohd Syed Ahangar, Selena G. Burgess, Mark W. Richards, Arnout P. Kalverda, Richard Bayliss
Journal:
Biochemical Journal
Biochem J (2024) 481 (21): 1535–1556.
Published: 21 October 2024
... in growth and development, but also have well documented pathological roles as oncoproteins in a wide variety of cancers [ 1–3 ]. The N-myc gene was discovered in a neuroblastoma cell line as a copy number amplified DNA sequence with sequence similarity to c-myc [ 4 ]. It is an important driver for cancers...
Includes: Supplementary data
Articles
Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2020) 477 (20): 4053–4070.
Published: 29 October 2020
... and function of neurons. The Trks share a high degree of homology and utilize overlapping signaling pathways, yet their signaling is associated with starkly different outcomes in certain cancers. For example, in neuroblastoma, TrkA expression and signaling correlates with a favorable prognosis, whereas TrkB...
Includes: Supplementary data
Articles
Specific keratinase derived designer peptides potently inhibit A β aggregation resulting in reduced neuronal toxicity and apoptosis
Available to PurchaseRinky Rajput, Balasubramani G L, Ankit Srivastava, Divya Wahi, Nidhi Shrivastava, Bishwajit Kundu, Abhinav Grover
Journal:
Biochemical Journal
Biochem J (2019) 476 (12): 1817–1841.
Published: 28 June 2019
... ) * These authors contributed equally to this work. 12 3 2019 22 5 2019 27 5 2019 28 5 2019 © 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2019 aggregation Alzheimer disease amyloid-beta neuroblastoma peptides toxicity...
Includes: Supplementary data
Articles
Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2018) 475 (2): 531–545.
Published: 31 January 2018
... that elevated mRNA levels of the two target enzymes DHPS and ODC correlate with poor prognosis in a large cohort of neuroblastoma (NB) tumors. The DHPS inhibitor GC7 ( N 1 -guanyl-1,7-diaminoheptane) and the ODC inhibitor α-difluoromethylornithine (DFMO) are target-specific and in combination induced...
Includes: Supplementary data
Articles
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex
Available to PurchaseVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, Mayumi Higashi, Sriharsha Kolla, Gerd A. Blobel, Garrett M. Brodeur
Journal:
Biochemical Journal
Biochem J (2015) 468 (2): 345–352.
Published: 22 May 2015
...-binding protein 5) is a tumour suppressor gene (TSG) that maps to a region of consistent deletion on 1p36.31 in neuroblastomas (NBs) and other tumour types. CHD5 encodes a protein with chromatin remodelling, helicase and DNA-binding motifs that is preferentially expressed in neural and testicular tissues...
Includes: Supplementary data
Articles
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
Available to PurchaseChristina Schönherr, Kristina Ruuth, Yasuo Yamazaki, Therese Eriksson, James Christensen, Ruth H. Palmer, Bengt Hallberg
Journal:
Biochemical Journal
Biochem J (2011) 440 (3): 405–414.
Published: 28 November 2011
...Christina Schönherr; Kristina Ruuth; Yasuo Yamazaki; Therese Eriksson; James Christensen; Ruth H. Palmer; Bengt Hallberg Mutations in the kinase domain of ALK (anaplastic lymphoma kinase) have recently been shown to be important for the progression of the childhood tumour neuroblastoma...
Includes: Supplementary data
Articles
Giuseppe Filomeni, Simone Cardaci, Ana Maria Da Costa Ferreira, Giuseppe Rotilio, Maria Rosa Ciriolo
Journal:
Biochemical Journal
Biochem J (2011) 437 (3): 443–453.
Published: 13 July 2011
... compilation © 2011 Biochemical Society 2011 AMP-activated protein kinase (AMPK) 3-bromo-pyruvate delocalized lipophilic cation neuroblastoma p38 mitogen-activated protein kinase (p38 MAPK ) p53 Extracellular lactate concentration was assessed as described previously [ 33 ]. Briefly, 10 μl...
Includes: Supplementary data
Articles
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain
Available to PurchaseChristian C. Lee, Yong Jia, Nanxin Li, Xiuying Sun, Kenneth Ng, Eileen Ambing, Mu-Yun Gao, Su Hua, Connie Chen, Sungjoon Kim, Pierre-Yves Michellys, Scott A. Lesley, Jennifer L. Harris, Glen Spraggon
Journal:
Biochemical Journal
Biochem J (2010) 430 (3): 425–437.
Published: 27 August 2010
... within the full-length ALK kinase domain, most commonly R1275Q and F1174L, which play a major role in neuroblastoma, were recently identified. To provide a structural framework for understanding these mutations and to guide structure-assisted drug discovery efforts, the X-ray crystal structure...
Includes: Supplementary data
Articles
Journal:
Biochemical Journal
Biochem J (2009) 420 (3): 345–361.
Published: 27 May 2009
...-small cell lung cancer), together with the identification of activating point mutations in neuroblastoma, have highlighted ALK as a significant player and target for drug development in cancer. In the present review we address the role of ALK in development and disease and discuss implications...
Articles
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2008) 416 (2): 153–159.
Published: 12 November 2008
...Helena Carén; Frida Abel; Per Kogner; Tommy Martinsson ALK (anaplastic lymphoma kinase) is oncogenic in several tumours and has recently been identified as a predisposition gene for familial NB (neuroblastoma) harbouring mutations in the TKD (tyrosine kinase domain). We have analysed a large set...
Articles
Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1
Available to PurchaseIulia Mocan, Florian Georgescauld, Philippe Gonin, Didier Thoraval, Laura Cervoni, Anna Giartosio, Sandrine Dabernat-Arnaud, Marc Crouzet, Marie-Lise Lacombe, Ioan Lascu
Journal:
Biochemical Journal
Biochem J (2007) 403 (1): 149–156.
Published: 13 March 2007
... (and deoxynucleoside) 5′-triphosphate. It is involved in complex cellular regulatory functions including the control of metastatic tumour dissemination. The mutation S120G has been identified in high-grade neuroblastomas. We have shown previously that this mutant has a folding defect: the urea-denatured protein could...
Articles
Proteasome-mediated effects on amyloid precursor protein processing at the γ-secretase site
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2005) 385 (2): 545–550.
Published: 07 January 2005
... (amyloid precursor protein) by various cell lines in vitro . Proteasome activity is altered during aging, a major risk factor for Alzheimer's disease. In the present study, a human neuroblastoma cell line expressing the C-terminal 100 residues of APP (SH-SY5Y-SPA4CT) was used to determine the effect...
Articles
Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor γ activation induced by 15-deoxyΔ 12,14 -prostaglandin J 2 in neuroblastoma cells
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2004) 382 (1): 83–91.
Published: 10 August 2004
...Helen A. RODWAY; Alan N. HUNT; Janice A. KOHLER; Anthony D. POSTLE; Karen A. LILLYCROP PPARγ (peroxisome proliferator-activated receptor γ) is a ligand-activated transcription factor that responds to 15dPGJ 2 (15-deoxy-Δ 12,14 -prostglandin J 2 ). 15dPGJ 2 , in vitro , halts neuroblastoma cell...
Articles
Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2004) 380 (2): 571–579.
Published: 01 June 2004
...Daniel NIELSEN; Hanna GYLLBERG; Pernilla ÖSTLUND; Tomas BERGMAN; Katarina BEDECS We have previously shown that ScN2a cells (scrapie-infected neuroblastoma N2a cells) express 2-fold- and 4-fold-increased levels of IR (insulin receptor) and IGF-1R (insulin-like growth factor-1 receptor) respectively...
Articles
Proprotein convertase PACE4 is down-regulated by the basic helix–loop–helix transcription factor hASH-1 and MASH-1
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2001) 360 (3): 683–689.
Published: 10 December 2001
... PACE4 gene expression in neural development, we analysed the effects of human achaete–scute homologue 1 (hASH-1) on PACE4 gene expression with various neuroblastoma cell lines. The expressions of PACE4 and hASH-1 are correlated inversely in these cell lines. The overexpression of hASH-1 or MASH-1 causes...
Articles
Ligand binding directly stimulates ubiquitination of the inositol 1,4,5-trisphosphate receptor
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2000) 348 (3): 551–556.
Published: 07 June 2000
... expressed ‘exogenous’ wild-type and ligand-binding-defective mutant type I Ins(1,4,5) P 3 receptors in human neuroblastoma SH-SY5Y cells, in which muscarinic receptor activation elicits Ins(1,4,5) P 3 receptor down-regulation. We found (1) that exogenous wild-type Ins(1,4,5) P 3 receptors are efficiently...